SunBio, Inc.
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
067370 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 남동구 은봉로 129 -, 인천광역시
- Website:
- http://www.sunbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SunBio, Inc. is a biotechnology company that develops, produces, and commercializes biosimilars, biopharmaceuticals, and medical devices. The company's core research and development activities are based on its proprietary PEGylation technology, a platform used to enhance the efficacy and duration of therapeutic drugs. Key products in its pipeline include an artificial blood substitute and MucoPEG, a treatment for xerostomia (dry mouth).
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SunBio, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all SunBio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SunBio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
